Mendez, Jemima M.

HRN: 29-39-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
CO-AMOXICLAV 625MG (TAB)
07/29/2026
08/05/2026
ORAL
625mg
BID
URTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  URTI    Compliance to guidelines: